首页> 外文OA文献 >Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population

【2h】

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population

机译：血液抑制患者患者曲妥珠单抗疗效的疗效比较，所述转移性人体表皮生长因子患者2阳性乳腺癌及仅在日本人群中的曲妥珠单抗治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shoko Noda-Narita; Akihiko Shimomura; Asuka Kawachi; Hitomi Sumiyoshi-Okuma; Kazuki Sudo; Tatsunori Shimoi; Emi Noguchi; Kan Yonemori; Chikako Shimizu; Yasuhiro Fujiwara; Kenji Tamura;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population [J] . Shoko Noda-Narita, Akihiko Shimomura, Asuka Kawachi, Breast cancer . 2019,第4期

机译：曲妥珠单抗氨丹宁在先前使用曲妥珠单抗和帕妥珠单抗联合治疗以及仅在日本人群中联合曲妥珠单抗治疗的转移性人类表皮生长因子受体2阳性乳腺癌患者之间的疗效比较
2. Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1) [J] . Baez-Vallecillo Luis, Raghavendra Akshara S., Hess Kenneth R., Breast cancer research and treatment. . 2019,第1期

机译：Lapatinib在转移性人体表皮生长因子受体2阳性乳腺癌中的活性，接受曲妥珠单抗，Pertuzumab和/或Ado-Trastuzumab Omtansine（T-DM1）的治疗
3. Effects of trastuzumab emtansine (T-DM1) on Qt interval and safety of pertuzumab plus T-DM1 in patients with previously treated human epidermal growth factor receptor 2-positive metastatic breast cancer [J] . GuptaM., WangB., CarrothersT.J., Clinical pharmacology in drug development . 2013,第1期

机译：曲妥珠单抗Emtansine（T-DM1）对先前治疗过的人表皮生长因子受体2阳性转移性乳腺癌患者Qt间隔和帕妥珠单抗加T-DM1安全性的影响
4. Identification of Human Epidermal Growth Factor Receptor 2 Antagonist In Silico for Breast Cancer Therapy, Derived from Indonesian Phytochemicals [C] . Tuti Ratnasari, Dono indarto, Raden Ajeng Sri Wulandari, International Conference on Biomedical Engineering . 2018

机译：人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population [O] . Shoko Noda-Narita, Akihiko Shimomura, Asuka Kawachi, -1

机译：曲妥珠单抗氨丹宁在仅使用过曲妥珠单抗和帕妥珠单抗联合曲妥珠单抗治疗且仅在日本人群中治疗的转移性人类表皮生长因子受体2阳性乳腺癌患者之间的疗效比较
7. Trastuzumab emtansine with or without pertuzumab versus trastuzumab plus taxane for human epidermal growth factor receptor 2-positive, advanced breast cancer: Primary results from the phase III MARIANNE study [O] . Perez, Edith A., Barrios, Carlos, Eiermann, Wolfgang, 2017

机译：曲妥珠单抗Emtansine联合或不联合帕妥珠单抗与曲妥珠单抗加紫杉烷治疗人表皮生长因子受体2阳性晚期乳腺癌：MARIANNE III期研究的主要结果

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population

著录项

引文网络

相似文献

相关主题

期刊订阅